UFP Technologies UFPT Q2 2026: EPS of $2.92 Breaks Eight-Quarter Plateau
As seen on the 24/7 Wall St. homepage on August 3, 2026.
UFP Technologies broke eight straight quarters of EPS near $2.40 to $2.50 as MedTech outside its top five customers grew 19.7%, with non-medical flat. Management flagged Dominican Republic ramp costs still pressuring U.S. margins, the key question on Tuesday's call.
Continue ReadingShow less
For eight consecutive quarters, UFP Technologies had kept its earnings per share in a remarkably tight band between roughly $2.39 and $2.50. Q2 2026 snapped that pattern decisively, with reported EPS of $2.92 coming in about 14% above the consensus estimate of $2.56. Revenue of $174 million also cleared expectations by more than 9%, against an estimated $159.4 million.
The catalyst behind the EPS jump was MedTech business outside UFP's top five customers, which grew 19.7% in the quarter. Non-medical revenue was essentially flat, so the outperformance was largely a medical-segment story. That concentration of growth in a broader, more diversified slice of the MedTech customer base could signal that the company is expanding its reach beyond its largest accounts.
Sponsored
Don't wait: the analyst who called NVIDIA in 2010 just revealed his top 10 AI stocks. See the full list FREE now.
Investors and analysts will be watching the Dominican Republic operations closely after management flagged that ramp-up costs there are still weighing on U.S. margins. That topic was identified as the central question heading into Tuesday's earnings call, and how management frames the timeline and magnitude of those costs will likely set the tone for how the market interprets an otherwise strong quarter.
Mentioned: UFPT